Dr. Samuel Clyde Spalding III, MD

  • Liverpool, NY
  • Retina specialist (ophthalmology) physician
NPI1356337562PAC ID9739265661
Medicare services, 2024
17,129
Medicare patients, 2024
1,023
Part D claims, 2024
316
Publications
1
MIPS score, 2024
100
Practice address
200 Greenfield Pkwy, Liverpool, NY 13088
Practice phone
Call (315) 445-8166
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Retina-Vitreous Surgeons of Central New York

Liverpool, New York

See all 6 affiliations

Find Dr. Spalding's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Samuel Clyde Spalding III is a retina specialist (ophthalmology) physician in Liverpool, New York

Dr. Spalding practices at Retina-Vitreous Surgeons of Central New York in Liverpool, New York.

Dr. Spalding's NPI, 1356337562, was assigned on September 22, 2005. Dr. Spalding graduated from University of Louisville School of Medicine in 1983. Dr. Spalding holds New York license 177673.

NPI and contact details
Medicare PAC ID
9739265661
NPI enumeration date
September 22, 2005
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(315) 445-8166
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
69
Medical school graduation
1983

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Samuel Clyde Spalding III practices at Retina-Vitreous Surgeons of Central New York in Liverpool, New York

Dr. Spalding's primary practice is Retina-Vitreous Surgeons of Central New York, at 200 Greenfield Pkwy, Liverpool, NY 13088 in Onondaga County. The practice phone is (315) 445-8166.

  • Retina-Vitreous Surgeons of Central New York
    200 Greenfield Pkwy, Liverpool, NY 13088 · Onondaga CountyPhone(315) 445-8166

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dr. Samuel Clyde Spalding III is affiliated with 4 sites of care and 2 medical groups

Dr. Spalding's primary practice is Retina-Vitreous Surgeons of Central New York in Liverpool, New York. Dr. Spalding is also affiliated with Upstate University Hospital. Dmand AI also links Dr. Spalding to 2 more group practices and clinics and 2 medical groups, each named with a free account.

See all 6 affiliations for Dr. Spalding

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. Samuel Clyde Spalding III's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Spalding practices, 3 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Retina-Vitreous Surgeons of Central New YorkAvailable with a free account
+3 more sites and 2 medical groupsAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Spalding practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Samuel Clyde Spalding III is one of 96 retina specialist (ophthalmology) physicians in New York

Retina specialist is Dr. Spalding's primary specialty in the NPI Registry, under taxonomy code 207WX0107X. Dr. Spalding is licensed in New York.

Specialties and state licenses

  • Retina specialist (ophthalmology), New YorkPrimaryLicense 177673 · taxonomy 207WX0107X

Retina specialist (ophthalmology) physicians near Dr. Spalding

Counts of retina specialist (ophthalmology) physicians with a Dmand AI profile, by place and practice. Each opens the list.

96retina specialist (ophthalmology) physicians in New York
7retina specialist (ophthalmology) physicians in Liverpool

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Samuel Clyde Spalding III billed Medicare for 17,129 services in 2024

CMS data shows 17,129 Medicare services from Dr. Spalding across 16 procedure codes in 2024, for 1,023 Medicare patients. Medicare paid $2,806,360 for them. Every service was in an office.

Medicare services, 202417,129
Medicare patients1,023
Paid by Medicare$2.8M
Procedure codes16

Dr. Spalding's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Drugs given in the office
2023: 3,7912024: 11,426201%
Tests and treatments
2023: 2,7762024: 3,28618%
Surgery
2023: 1,4672024: 1,91430%
Office and hospital visits
2023: 5772024: 50313%

Dr. Spalding compared with the New York median for retina specialist (ophthalmology) physicians, 2024

  • Dr. Spalding
  • New York median
Medicare services
17,129vs 6,9442.5 times
Medicare patients
1,023vs 54488% above
Part D claims
277vs 52247% below

Medians across 94 retina specialist (ophthalmology) physicians in New York with Dmand AI profiles that report each measure.

Dr. Spalding's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Spalding

Need commercial claims for Dr. Spalding?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Spalding and other retina specialist (ophthalmology) physicians in New York.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Samuel Clyde Spalding III treated 1,023 Medicare patients in 2024, average age 78

CMS counts 1,023 Medicare patients who saw Dr. Spalding in 2024. The largest group is 75 to 84, with 371 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Spalding's median patient age at 73, with 57% women.

Medicare patients, 20241,023
Average age78
Average risk score1.53
Also on Medicaid11%

Dr. Spalding's Medicare patients by age, 2024

Dr. Spalding's Medicare patients by sex, 2024

  • Women58257%
  • Men44143%

Chronic conditions among Dr. Spalding's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol75%
  3. Arthritis42%
  4. Diabetes38%
  5. Chronic kidney disease31%
  6. Ischemic heart disease30%
  7. Atrial fibrillation24%
  8. Anxiety23%

Share of Medicare patients with each condition. A patient can have several.

Dr. Spalding's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 73

Patient panel by sex, all payers

  • Women57%
  • Men42%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Samuel Clyde Spalding III wrote 316 Medicare Part D claims in 2024

In 2024, Dr. Spalding wrote 316 Medicare Part D claims for 114 patients. 57% of them were for generic drugs. CMS names the drug for 277 of them, across 5 drugs with 11 or more claims each, at $8,092 in total drug cost. In 2023, CMS named 167 claims across 4 drugs.

Part D claims, 2024316
Drugs named by CMS5
Total drug cost$8,092
Part D patients114

Dr. Spalding's Part D claims by kind of drug, 2024

  • Generic181 claims57%
  • Brand-name135 claims43%

Dr. Spalding's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 1672024: 27766%

Drugs named by CMS: 5 in 2024, 4 in 2023.

See all prescribing by Dr. Spalding

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Samuel Clyde Spalding III scored 100 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Spalding for performance year 2024, reported as part of a group. Dr. Spalding accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Dr. Spalding's MIPS scores, performance year 2024

  • 100of 100Final score
  • 100of 100Quality
  • 40of 100Improvement Activities

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find retina specialist (ophthalmology) physicians like Dr. Spalding by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Samuel Clyde Spalding III has 1 publication on record

Dmand AI links 1 paper to Dr. Spalding in 2023. Dr. Spalding's most frequent co-authors are Mark Philip Breazzano, MD, Robert T. Swan, MD and Robert William Weisenthal, MD.

Papers1

Dr. Spalding's most frequent co-authors

Recent publications by Dr. Spalding

See all 1 publications and co-authors

See who Dr. Spalding researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Spalding works with, so you can find a warm path to the right retina specialist (ophthalmology) physicians.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Samuel Clyde Spalding III received $14,778 in industry payments from 2016 to 2025

CMS Open Payments shows 18 general payments to Dr. Spalding from 7 drug and device companies from 2016 to 2025. Acquisitions make up the largest share, 56% of the total. US Retina LLC paid the most, $14,307.

General payments to Dr. Spalding by program year, 2016 to 2025

General payments to Dr. Spalding by kind, 2016 to 2025

$14.8Kin total
  • Acquisitions$8,31556%
  • Ownership or investment$5,99241%
  • Food and beverage$4713%

Companies that paid Dr. Spalding the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Spalding

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Samuel Clyde Spalding III graduated from University of Louisville School of Medicine

Dr. Spalding graduated from University of Louisville School of Medicine in 1983.

  1. Medical schoolUniversity of Louisville School of Medicine

Source: Dmand AI Professional Profile Data

Sources for Dr. Samuel Clyde Spalding III's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Samuel Clyde Spalding III

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Samuel Clyde Spalding III's NPI number?

Dr. Samuel Clyde Spalding III's NPI number is 1356337562. It was assigned on September 22, 2005, and it is active in the NPI Registry.

What kind of doctor is Dr. Samuel Clyde Spalding III?

Dr. Samuel Clyde Spalding III is a retina specialist (ophthalmology) physician in Liverpool, New York. The primary specialty in the NPI Registry is Retina Specialist (Ophthalmology) Physician (taxonomy code 207WX0107X).

Where does Dr. Samuel Clyde Spalding III practice?

Dr. Spalding practices at 200 Greenfield Pkwy, Liverpool, NY 13088. Dr. Spalding's primary practice is Retina-Vitreous Surgeons of Central New York in Liverpool, New York. Dmand AI also links Dr. Spalding to 2 group practices and clinics and 2 medical groups.

What is Dr. Samuel Clyde Spalding III's office phone number?

The practice phone on file for Dr. Spalding is (315) 445-8166.

What is Dr. Samuel Clyde Spalding III's medical license number?

Dr. Spalding holds New York license 177673.

Which hospitals is Dr. Samuel Clyde Spalding III affiliated with?

Dr. Spalding is affiliated with Upstate University Hospital.

Does Dr. Samuel Clyde Spalding III accept Medicare?

Yes. CMS data shows Dr. Spalding billed Medicare for 17,129 services in 2024, and Dr. Spalding accepts Medicare assignment.

What is Dr. Samuel Clyde Spalding III's MIPS score?

Dr. Spalding's MIPS final score for performance year 2024 is 100 out of 100, reported as part of a group.

How many Medicare patients does Dr. Samuel Clyde Spalding III see?

CMS counts 1,023 Medicare patients who saw Dr. Spalding in 2024, with an average age of 78.

What services does Dr. Samuel Clyde Spalding III bill to Medicare?

In 2024, Dr. Spalding's most billed Medicare services were injected or infused drug (J2777), injected or infused drug (J0178) and eye exam or test (92134).

Show 6 more questionsShow fewer questions

Where did Dr. Samuel Clyde Spalding III go to medical school?

Dr. Spalding graduated from University of Louisville School of Medicine in 1983.

What drugs does Dr. Samuel Clyde Spalding III prescribe most?

In 2024 Medicare Part D data, Dr. Spalding's most prescribed drugs by claims were Prednisolone Acetate, Ketorolac Tromethamine and Tobramycin.

Has Dr. Samuel Clyde Spalding III received payments from drug or device companies?

CMS Open Payments shows $14,778 in general payments to Dr. Spalding from 7 companies from 2016 to 2025. The largest total came from US Retina LLC.

How long has Dr. Samuel Clyde Spalding III been practicing?

Dr. Spalding graduated from medical school in 1983, 43 years ago.

Does Dr. Samuel Clyde Spalding III do research?

Dmand AI links 1 publication to Dr. Spalding.

Who does Dr. Samuel Clyde Spalding III publish with?

Dr. Spalding's most frequent co-authors are Mark Philip Breazzano, MD (1 shared paper), Robert T. Swan, MD (1 shared paper) and Robert William Weisenthal, MD (1 shared paper).

Selling to retina specialist practices?

See retina specialist (ophthalmology) physicians in New York by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)